Joseph W Lubach (Joseph Lubach)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Ankylosing Spondylitis

Attention Deficit Hyperactivity Disorder

Tyrosine Kinase

Top Venues

Molecular pharmaceutics

Organic letters

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Helen J Zhang, Cheng W Chiang, Tristan Maschmeyer-Tombs, Breanna Conklin, Jose G Napolitano, Joseph W Lubach, Karthik Nagapudi, Chen Mao, Yinshan Chen
Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide. Molecular pharmaceutics (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing. Molecular pharmaceutics 21 (2) (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing. Molecular pharmaceutics (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing. Molecular pharmaceutics 21 (2) (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Correction to "Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing". Molecular pharmaceutics 21 (6) (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Correction to "Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing". Molecular pharmaceutics (2024)
Helen J Zhang, Cheng W Chiang, Tristan Maschmeyer-Tombs, Breanna Conklin, Jose G Napolitano, Joseph W Lubach, Karthik Nagapudi, Chen Mao, Yinshan Chen
Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide. Molecular pharmaceutics 21 (7) (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing. Molecular pharmaceutics 21 (2) (2024)
Cheng W Chiang, Joseph W Lubach, Tao Chen, Steven Chin, Justin Ly, Wei Zhang, Hao Helen Hou, Karthik Nagapudi
Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies. Molecular pharmaceutics (2023)
Rick W Dorn, Brendan J Wall, Sarah B Ference, Sean R Norris, Joseph W Lubach, Aaron J Rossini, Brett VanVeller
Attached Nitrogen Test by 13 C- 14 N Solid-State NMR Spectroscopy for the Structure Determination of Heterocyclic Isomers. Organic letters 24 (31) (2022)
Yinshan Chen, Joseph W Lubach, Shijia Tang, Ajit S Narang
Effect of Counterions on Dissolution of Amorphous Solid Dispersions Studied by Surface Area Normalized Dissolution. Molecular pharmaceutics 18 (9) (2021)
David A Hirsh, Anuradha V Wijesekara, Scott L Carnahan, Ivan Hung, Joseph W Lubach, Karthik Nagapudi, Aaron J Rossini
Rapid Characterization of Formulated Pharmaceuticals Using Fast MAS 1H Solid-State NMR Spectroscopy. Molecular pharmaceutics 16 (7) (2019)
Dawen Kou, Chen Zhang, Hiuwing Yiu, Tania Ng, Joseph W Lubach, Matthew Janson, Chen Mao, Matthew Durk, Leslie Chinn, Helen Winter, Larry Wigman, Peter Yehl
In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound. Molecular pharmaceutics 15 (4) (2018)
Abbe Haser, Tu Cao, Joseph W Lubach, Feng Zhang
In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion. Molecular pharmaceutics 15 (3) (2018)
James J Crawford, Adam R Johnson, Dinah L Misner, Lisa D Belmont, Georgette M Castanedo, Regina Choy, Melis Coraggio, Liming Dong, Charles Eigenbrot, Rebecca Erickson, Nico Ghilardi, Jonathan Hau, Arna Katewa, Pawan Bir Kohli, Wendy Lee, Joseph W Lubach, Brent S McKenzie, Daniel F Ortwine, Leah Schutt, Suzanne Tay, BinQing Wei, Karin Reif, Lichuan Liu, Harvey Wong, Xiaojing Wang
Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton's Tyrosine Kinase Inhibitor in Early Clinical Development. Journal of medicinal chemistry 61 (6) (2018)
Paroma Chakravarty, Antonio G DiPasquale, Andreas Stumpf, Joseph W Lubach, Karthik Nagapudi
Understanding Phase Behavior of Nearly Energetically Equivalent Polymorphs To Achieve Controlled Crystallization for a Nav1.7 Pain Inhibitor Compound. Molecular pharmaceutics 15 (11) (2018)
Kassibla Elodie Dempah, Joseph W Lubach, Eric J Munson
Characterization of the Particle Size and Polydispersity of Dicumarol Using Solid-State NMR Spectroscopy. Molecular pharmaceutics 14 (3) (2017)
Arjun Kalra, Patrick Tishmack, Joseph W Lubach, Eric J Munson, Lynne S Taylor, Stephen R Byrn, Tonglei Li
Impact of Supramolecular Aggregation on the Crystallization Kinetics of Organic Compounds from the Supercooled Liquid State. Molecular pharmaceutics 14 (6) (2017)
Kassibla Elodie Dempah, Joseph W Lubach, Eric J Munson
Correction to "Characterization of the Particle Size and Polydispersity of Dicumarol Using Solid-State NMR Spectroscopy". Molecular pharmaceutics 14 (4) (2017)